NEO212: sub-cytotoxic doses capable of inhibiting glioma stem cell invasion

Oncoscience. 2018 Jun 27;5(5-6):148-149. doi: 10.18632/oncoscience.429. eCollection 2018 May.

Authors

Nagore I Marín-Ramos¹, Florence M Hofman¹, Thomas C Chen¹

Affiliation

¹ Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

No abstract available

Keywords: NEO212; glioblastoma; glioma stem cells (GSC); invasion; temozolomide (TMZ).

Publication types

Editorial